Thank you, Madam Chairperson.
And thank you, Dr. Prigent and Dr. Beaudet, for being here.
I want to begin by saying, Dr. Prigent, that I have no doubts about your professional expertise, your integrity, or your significant experience. This is really about whether it makes sense to have someone who is currently a vice-president, or in any position with a major drug company, sitting on the governing council of the CIHR. I know you said the governing council doesn't actually give out money. The governing council governs the CIHR, whose mandate is to make decisions about where to target money, what priority areas should be focused on, how we can increase the research capacity in this country, and how we can support a new generation of health researchers. So it is rather important.
My question to you and to Dr. Beaudet, who I believe submitted your name in the first place--